IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 21 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,147 | -63.2% | 15,927 | -40.4% | 0.00% | – |
| Q2 2023 | $79,144 | -0.3% | 26,738 | -6.7% | 0.00% | – |
| Q1 2023 | $79,366 | +54260.3% | 28,652 | +3.6% | 0.00% | – |
| Q4 2022 | $146 | -99.9% | 27,661 | +12.6% | 0.00% | – |
| Q3 2022 | $98,000 | +66.1% | 24,573 | +59.9% | 0.00% | – |
| Q2 2022 | $59,000 | -11.9% | 15,364 | +17.2% | 0.00% | – |
| Q1 2022 | $67,000 | -10.7% | 13,113 | +4.6% | 0.00% | – |
| Q2 2021 | $75,000 | – | 12,538 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 1,028,253 | $1,882 | 0.09% |
| Gradient Capital Advisors, LLC | 26,808 | $49,059 | 0.02% |
| WEST PACES ADVISORS INC. | 1,665 | $3,047 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 15,927 | $29,147 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,382 | $4,359 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 17,484 | $31,995 | 0.00% |
| CITIGROUP INC | 7 | $13 | 0.00% |
| MORGAN STANLEY | 533 | $975 | 0.00% |
| Rathbones Group PLC | 14,000 | $25,620 | 0.00% |